Disruption of Sarcolemmal ATP-Sensitive Potassium Channel Activity Impairs the Cardiac Response to Systolic Overload
A TP-sensitive potassium channels (K ATP ) act as metabolic sensors that can regulate cellular activity to meet energetic demands. 1 In the cardiac myocyte, K ATP channels are composed of the pore forming subunit Kir6.2 and the regulatory subunit SUR2A. Patients with missense or frameshift mutations in genes encoding the cardiac K ATP channel are predisposed to cardiomyopathy or sudden death. 2, 3 Moreover, in genetically modified mouse models, global Kir6.2 gene knockout (Kir6.2 KO) resulted in abolition of ischemic preconditioning, 4 reduced exercise capacity, 5 impaired the response to adrenergic challenge, 6 compromised the tolerance to hypertension, 7 and impaired the ability to tolerate hemodynamic overload produced by transverse aortic constriction (TAC). 8 Two recent studies using Kir6.2 KO mice reported that disruption of K ATP channel activity led to activation of calcium-dependent calcineurin pathways, which, in turn, increased nuclear accumulation of the prohypertrophic transcription factors MEF2 and NFAT. 7, 8 However, the molecular mechanisms by which K ATP channels regulate cardiac function, particularly during adaptation of the heart to the increased metabolic requirements produced by hemodynamic overload, are largely unknown. Most importantly, as a well defined metabolic stress sensor, the role of K ATP channels in regulation of genes related to myocardial metabolism has not been studied.
At the transcriptional level, several families of transcription factors have been identified that regulate energy production processes, including peroxisome proliferator-activated receptor (PPAR), 9 estrogen-related receptor (ERR), 10, 11 nuclear respiratory factor (NRF), 12 Tfam (mitochondrial transcription factor A), 13 PPAR␥ coactivator-1␣ (PGC-1␣), and PGC-1␤. 14 PGC-1␣ and PGC-1␤ bind to both nuclear receptors and nonnuclear receptors and control cellular energy metabolic pathways. In transgenic mice, overexpression of PGC-1␣ resulted in massive proliferation of enlarged mitochondria in the heart, 15 whereas PGC-1␣-deficient mice showed decreased myocardial mitochondrial enzymes and diminished cardiac function in response to an increased workload. 16, 17 PGC-1␣ expression is repressed by insulin in HepG2 cells and skeletal muscle through the 3 insulin response sequences (IRSs) in the PGC-1␣ promoter. 18, 19 Insulin exerts its function through activation of Akt, which, in turn, phosphorylates FOXO1, one of the positive regulators of PGC-1␣ transcription. Phosphorylated FOXO1 is exported out of the nuclei and targeted for degradation. 20 Here, using both Kir6.2 KO mice 21 and a transgenic mouse strain in which ventricular K ATP channel activity was disrupted by cardiac-specific overexpression of the K ATP channel regulatory subunit SUR1 (SUR1-tg), 22 we demonstrate that loss of K ATP channel activity attenuates the expression of PGC-1␣ and mitochondrial energy metabolism-related enzymes in the heart exposed to pressure overload, indicating a role for K ATP channels in the chronic response to increased cardiac work. We provide further evidence that the protective effect of K ATP occurs at least partially by regulating the activity of FOXO1, which, in turn, influences the expression of PGC-1␣ and its downstream target genes.
Materials and Methods
SUR1-tg mice, 22 Kir6.2 KO mice, 21 and PGC-1␣ KO mice (gifts from Dr Daniel Kelly) 23 were used in this study according to a protocol approved by the University of Minnesota Institutional Animal Care and Use Committee. Transverse aortic constriction (TAC) was used to create systolic pressure overload as previously described. 24, 25 An expanded Methods section is available in the online data supplement at http://circres.ahajournals.org.
Results

Disruption of K ATP Channels Exacerbated Left Ventricular Hypertrophy and Dysfunction Produced by TAC
Similar to previous reports, 22 mice with disrupted cardiac K ATP channel activity secondary to cardiac-specific SUR1 overexpression develop and grow similarly to their wild-type (WT) littermates under normal conditions and had normal cardiac function under unstressed conditions (Table I in the online data supplement). Left ventricular (LV) dimensions and ejection fraction of the Kir6.2 KO were also similar to their WT control mice under unstressed conditions, consistent with previous reports. 7, 8 The sustained TAC will increase myocardial ATP demands and may compromise coronary perfusion to result in activation of K ATP channels; consequently, we performed TAC to stress the hearts of SUR1-tg and WT. As expected, 4 weeks of severe TAC produced significant ventricular hypertrophy in both WT and SUR1-tg mice; however, the degree of hypertrophy assessed by heart weight-to-body weight ratio was Ϸ15% greater in the SUR1-tg mice ( Figure 1A ). In addition, the cardiomyocyte cross-sectional area following TAC was significantly larger in SUR1-tg than in WT littermates (427Ϯ26 m 2 versus 359.3Ϯ14.4 m 2 , respectively, PϽ0.05). Both lung weight and lung weight-to-body weight ratio were significantly greater in the SUR1-tg mice as compared with WT following TAC ( Figure 1B ), indicating that SUR1-tg mice had more pulmonary congestion. Moreover, there was more LV dilation and greater impairment of LV function in SUR1-tg mice, with a greater decrease of LV ejection fraction than in the WT ( Figure 1C through 1E, supplemental Table I) .
Consistent with a greater degree of LV dysfunction, myocardial atrial natriuretic peptide (ANP) was significantly higher at both protein and mRNA levels in the SUR1-tg mice as compared with WT littermates after TAC ( Figure 1F and 1G and supplemental Figure I ). The expression level of Kir6.2 was not altered in response to TAC or ectopic expression of SUR1 (supplemental Figure I) .
To confirm that the greater ventricular hypertrophy and dysfunction in SUR1-tg mice was indeed attributable to loss of K ATP channel activity, we subsequently studied Kir6.2 KO mice. After 6 weeks of moderate TAC, Kir6.2 KO mice also developed more severe cardiac hypertrophy as compared with the WT mice (Figure 2A ), and this was associated with a small but significant increase of the ratio of lung weight-tobody weight in Kir6.2 KO mice ( Figure 2B ). There was also a trend toward a greater decrease of LV ejection fraction in the Kir6.2 KO mice, but this difference was not significant ( Figure 2C and 2D ). Kir6.2 KO also exacerbated the increase of myocardial ANP produced by TAC ( Figure 2E ). The mortality after TAC was not different between Kir6.2 KO and WT mice. Taken together, these data demonstrate that disruption of K ATP channels exacerbated TAC-induced LV dysfunction and indicate that K ATP channel activity is important for the compensatory responses that allow the heart to adapt to chronic systolic overload.
Disruption of K ATP Channels Attenuated Myocardial PGC-1␣ Expression in Response to Chronic Pressure Overload
Studies of the Kir6.2 KO mice indicate that the presence, and presumably activation, of K ATP channels during metabolic stress helps to preserve cellular ATP and maintain energy homeostasis. To determine whether disruption of K ATP channels in the SUR1-tg mice altered components of energy producing systems, we examined the expression of enzymes related to myocardial ATP production. We found that uncoupling protein-3 (UCP3), cytochrome c, cytochrome c oxidase subunit-III (COX-III), and carnitine palmitoyltransferase-1 muscle isoform (CPT-1b) were each significantly decreased in the SUR1-tg mice both under control conditions and after TAC ( Figure 3A through 3C and supplemental Figure II) , indicating that abnormal mitochondrial function might contribute to the LV dysfunction that we observed in the SUR1-tg mice after TAC. Furthermore, the mRNA content of very long chain acetyl-CoA dehydrogenase (VLCAD), medium chain acetyl-CoA dehydrogenase (MCAD), CPT-1b, COX-I, and COX-III were all significantly decreased in the SUR1-tg mice as compared with WT littermates under both control conditions and after TAC ( Figure 3D and supplemental Figure III) . Similarly, TAC caused significantly decreased expression of these enzymes in the Kir6.2 KO mice as compared with the WT mice ( Figure 3E ). These results indicate that disrupting K ATP channel activity attenuated the expression of mitochondrial energy metabolism related enzymes. However, there was no significant difference in myocardial mitochondrial volume density between the WT and SUR1-tg mice before or after TAC, suggesting that the quality, but not the quantity, of mitochondria was changed in the SUR1-tg hearts (supplemental Figure IV) . We also examined upstream transcriptional factors that have been shown to regulate energy metabolism related genes, including PGC-1␣, PGC-1␤, ERR␣, ERR␥, PPAR␣, PPAR␥, Tfam, and nuclear respiratory factor-1. TAC caused significant up regulation of PGC-1␣ and PPAR␣ in WT, although this induction was abolished by ablation of K ATP activity in the SUR1-tg mice ( Figure 4A ). Interestingly, myocardial PGC-1␣ protein content was significantly decreased in SUR1-tg mice compared with WT mice under both control conditions and after TAC ( Figure 4B and 4C). In addition, TAC caused significantly greater decreases of myocardial PGC-1␣ mRNA in Kir6.2 KO mice as compared with their WT littermates ( Figure 4D ). These data indicate that K ATP channel dysfunction leads to deregulation of PGC-1␣ expression and its downstream target genes in response to systolic overload.
Blocking K ATP Channel Activity in Rat Neonatal Cardiomyocytes Decreased the Promoter Activity and mRNA Level of PGC-1␣
A decrease in myocardial PGC-1␣ content has been reported in several heart failure models. 17, 26 However, changes of PGC-1␣ expression in vivo could be the result of altered neurohormonal signaling in the setting of heart failure, rather than a direct effect of K ATP activity. To determine whether inhibition of K ATP channel activity can directly affect PGC-1␣ expression in cardiac myocytes, we studied the effect of inhibiting K ATP channels on PGC-1␣ expression in rat neonatal cardiac myocytes. Because cardiac K ATP channels are likely to be closed in cultured cardiac myocytes under basal conditions, we challenged the cells with hypoxia/reoxygenation (H/R) to activate K ATP channels (24 hours of 1% oxygen followed by 7 to 8 hours of reoxygenation). K ATP channel activity was suppressed either pharmacologically with glibenclamide or by selective gene silencing of cardiac K ATP regulatory subunit, SUR2A. Both pharmacological and genetic suppression significantly repressed the expression of PGC-1␣ at the mRNA level ( Figure 5A and 5B). Expression of the 2 downstream targets of PGC-1␣ genes, CPT-1b and VLCAD, was also determined. The mRNA level of CPT-1b was significantly reduced by glibenclamide treatment or SUR2 gene silencing. The expression of VLCAD also tended to decrease after glibenclamide treatment ( Figure 5A and 5B). 
Circulation Research October 24, 2008
In a subsequent study, rat neonatal cardiomyocytes were transfected with a luciferase reporter driven by a 3.1-kb mouse PGC-1␣ promoter. 27 Either glibenclamide treatment or knocking down SUR2 expression significantly reduced reporter activity by Ϸ22% and 32%, respectively ( Figure 5C and 5D), suggesting that blocking K ATP channel activity can repress expression of PGC-1␣ at the transcriptional level.
PGC-1␣ KO Exacerbated Left Ventricular Hypertrophy and Dysfunction Produced by Moderate TAC
To determine whether a decrease of PGC-1␣ can contribute to pressure overload induced myocardial hypertrophy and dysfunction, we determined ventricular structure and function of PGC-1␣ KO and WT mice under control conditions and after 6 weeks of moderate TAC. Disruption of PGC-1␣ had no effect on cardiac functions during basal conditions ( Figure  6 ). However, 6 weeks of TAC caused significantly more hypertrophy in PGC-1␣ KO mice ( Figure 6A ). In addition, TAC caused significantly greater increases of the ratio of lung weight-to-body weight and LV end-systolic diameter, a greater decrease of LV ejection fraction ( Figure 6B through 6D), and a greater increase of ANP expression ( Figure 6E ), indicating that diminished PGC-1␣ exacerbated TACinduced ventricular hypertrophy and dysfunction.
Disruption of K ATP Activity in the SUR1-tg Mice Reduced Total FOXO1 After TAC
To this point, our findings indicate that cardiac K ATP channel dysfunction contributes to the repressed expression of PGC-1␣ during stress conditions. An important remaining question is which signaling pathway(s) provide the link(s) between K ATP activity and PGC-1␣ expression. It has been reported in HepG2 cells and in skeletal muscle that FOXO1 activates PGC-1␣ promoter through IRSs. Phosphorylation of FOXO1 at Thr24 by Akt decreases PGC-1␣ promoter activity by decreasing the nuclear FOXO1 associated with the PGC-1␣ promoter. 18, 19 To examine whether differences in the Akt-FOXO1 signaling pathway might be responsible for the down regulation of PGC-1␣ in the SUR1-tg mice, we compared the levels of total and phos-Akt Ser473 and total and phos-FOXO1 Thr24 in WT and SUR1-tg hearts by Western blot. As shown in Figure 7A and 7B, after TAC, total Akt was significantly increased in the SUR1-tg mice but not in the WT. TAC also caused an increase of phos-Akt Ser473 in both WT and SUR1-tg mice, but the amount of phos-Akt Ser473 was significantly higher in the SUR1-tg mice under both control conditions and after TAC. Moreover, although TAC had no effect on phos-FOXO1 Thr24 in either the SUR1-tg or the WT mice, it did cause a significant increase of total FOXO1 in the WT mice; however, this induction was abolished in the SUR1-tg mice ( Figure 7A and 7B) . The findings of unchanged phos-FOXO1 Thr24 but decreased total FOXO1 indicates that nuclear FOXO1 may be decreased in the SUR1-tg mice after TAC. To confirm this, we prepared nuclear extract from flash frozen heart samples. The SUR1-tg mice had a significantly decreased nuclear FOXO1 as compared with the sham group and WT banded mice. Interestingly, nuclear FOXO1 was slightly increased in the WT mouse heart following TAC but decreased in the SUR1-tg heart under basal conditions, although neither was statistically significant. The amount of cytoplasmic fraction of FOXO1 was not different among the 4 groups ( Figure 7C) . Similarly, TAC resulted in significantly decreased expression of both PGC-1␣ and FOXO1 in the Kir6.2 KO mice but not in WT mice ( Figure 7D ). Taken together, these data suggest that decreased FOXO1 might partially account for the repressed expression of PGC-1␣ when K ATP channel activity is disrupted.
We further examined the levels of Akt and FOXO1 and the subcellular distribution of FOXO1 in neonatal cardiomyocytes subjected to H/R, with or without disruption of K ATP . Under normoxic conditions, glibenclamide or silencing SUR2 gene expression did not activate Akt or change FOXO1 expression. Under hypoxic conditions, the amount of phosAkt Ser473 was increased when K ATP channels were pharmacologically blocked with glibenclamide or silencing SUR2 gene expression ( Figure 7E ). Furthermore, K ATP channel blockade significantly decreased the amount of FOXO1 in nuclei, whereas cytosolic FOXO1 was significantly increased. These data indicate that blocking K ATP channel activity under stress conditions leads to decreased nuclear FOXO1 and that increased phos-Akt Ser473 may be one of the factors that induces nuclear exclusion of FOXO1 when K ATP is disrupted.
Mutations of Potential FOXO1 Binding Sites on PGC-1␣ Promoter Abolished H/R-Induced PGC-1␣ Promoter Activity
To determine whether reduced nuclear FOXO1 leads to repression of PGC-1␣ promoter activity, point mutations were introduced into each IRS in the luciferase reporter construct and reporter activities were determined ( Figure 8A and 8B). After H/R, the promoter activity of PGC-1␣ was significantly decreased when the IRSs were mutated, indicating that these IRSs are important in maintaining PGC-1␣ promoter activity. Glibenclamide treatment further decreased the luciferase activity of the mutated reporters, suggesting that K ATP channels might influence the PGC-1␣ promoter through other pathway(s) in addition to FOXO1. Finally, chromatin immunoprecipitation assay was performed using anti-FOXO1 antibody ( Figure 8C ). Treatment with glibenclamide or knockdown of SUR2 subunit expression decreased the amount of FOXO1 associated with the IRSs. Taken together, these data indicate that inactivation of K ATP activity under stress conditions represses PGC-1␣ expression, at least partially through dissociation of the positive regulator FOXO1 from its promoter.
Discussion
The major finding of this study is that K ATP channels can regulate energy metabolism related gene expression through PGC-1␣. To our knowledge, this provides the first evidence that functional K ATP channels influence the expression of myocardial PGC-1␣ and the expression of a group of proteins related to ATP production. Thus, K ATP channels play a critical role in augmenting the myocardial energy supply during chronic hemodynamic overload by regulating PGC-1␣ expression at the transcriptional level.
In this study, we used cardiac-specific SUR1-tg mice in which ventricular K ATP channel activity is essentially abolished as the result of ectopic expression of the SUR1 regulatory subunit. 22 Using cardiac-specific disruption of K ATP channels avoids potential unwanted systemic effects of global gene deletion such as insulin secretion defects 28 or coronary spasm 29 that have been described in other global K ATP gene-deficient mouse strains. To confirm that our observations were caused by K ATP ablation, we also studied the effects of global depletion of the pore forming subunit in Kir6.2 KO mice. Our findings that disruption of K ATP exacerbated the TAC induced cardiac hypertrophy and dysfunction in both the SUR1-tg and the Kir6.2 KO mice are consistent with a previous report that disruption of K ATP impaired the tolerance of Kir6.2 KO mice to TAC-induced systolic overload. Those investigators reported that in response to TAC, action potential duration shortened in WT mice but was prolonged in Kir6.2 KO mice, a response that resulted in calcium overload in the Kir6.2 KO myocytes. 8 Interestingly, we now show that suppression of K ATP channel activity during TAC also disrupts the expression of PGC-1␣ via the FOXO1 signaling pathway. The link between K ATP channels and regulation of this master metabolic regulatory pathway remains to be determined, but several studies have demonstrated that [Ca 2ϩ ] i is able to regulate Akt activity. 30, 31 It is conceivable that disruption of K ATP channel activity led to Ca 2ϩ overload in the cardiomyocytes, 32 which, in turn, contributed to activation of Akt. The results of the present study demonstrate that K ATP channel activity affects the expression of metabolism related enzymes important for ATP production. In a recent study, Jilkina et al observed that the baseline ATP level in Kir6.2 KO hearts was decreased by 30%, and this difference was even more evident when the heart was stressed by metabolic inhibition or isoproterenol infusion. 33 We demonstrate here that some myocardial metabolic enzymes were decreased in unstressed SUR1-tg and Kir6.2 KO mice, suggesting that K ATP activity controls the expression of metabolic enzymes during control conditions. The depression of PGC-1␣ signaling as a result of K ATP suppression is likely to reduce the myocardial metabolic reserve available for energy production during increases of cardiac work 34 and may, thereby, provide a mechanistic basis for the link between K ATP activity and ATP production reported in Kir6.2 KO mice.
Previous studies have shown that defects of mitochondrial respiratory chain complexes can lead to LV dysfunction or cardiomyopathy. 35 Similarly, 2 PGC-1␣ knockout mouse models exhibited differing severities of cardiac phenotype, but both showed impairment of the cardiac response to stress (TAC, dobutamine challenge, or exhaustive exercise), 16, 17, 23 suggesting that PGC-1␣ becomes more critical during stress conditions, consistent with our findings of greater LV dysfunction and pulmonary congestion in PGC-1␣-null mice 
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following TAC. It should be noted that in the SUR1-tg study, PGC-1␣ mRNA was increased, whereas the PGC-1␣ protein was decreased in the WT mice after TAC. This disparity between mRNA and protein expression suggests that the expression of PGC-1␣ is regulated at the translational and/or posttranslational level in response to pressure overload. Our finding that PGC-1␣ mRNA was increased in WT mice after TAC is contrary to reports that TAC caused a decrease of myocardial PGC-1␣. 17, 26 This discrepancy may be the result of differences in the degree of LV dysfunction or the duration of TAC. However, TAC caused more ventricular hypertrophy and a greater decrease of PGC-1␣ in both SUR1-tg and Kir6.2 KO mice as compared with their corresponding WT littermates, indicating that intact K ATP activity is important for maintaining myocardial PGC-1␣ expression and ventricular function when the heart is stressed. Our previous studies consistently show that TAC induces myocardial Akt activation. 24, 25 Several studies using overexpression of activated Akt demonstrate that short-term Akt activation results in "physiological" hypertrophy, but chronic, unregulated Akt activation in the heart can be detrimental. 36, 37 Thus, both the extent and duration of Akt signaling are important in regulating cardiac function. Cardiac-specific overexpression of a constitutively active mutant of Akt (myr-Akt) leads to Ϸ2-fold reduction in expression of PPAR␣ and PGC-1␣ mRNA, suggesting that Akt may regulate the expression of these 2 genes, presumably through the phosphorylation and nuclear exclusion of phos-FOXO1. 38 In the present study, we observed increased phos-Akt in the SUR1-tg mice relative to WT in both unstressed and stressed conditions. In addition, disruption of K ATP channel activity in neonatal cardiac myocytes enhanced phosphorylation of Akt ( Figure 7E) . However, the activation of Akt did not correlate very well with FOXO1 protein levels in the SUR1-tg study. One possible explanation for this is that other signaling pathways that induce the nuclear retention of FOXO1 39 might overcome the Akt signaling that induces cytoplasmic localization of FOXO1. To this end, our results support the concept that disruption of K ATP channels enhanced TACinduced Akt activation. However, whether the increased Akt activation contributed to the decreased PGC-1␣ is uncertain. The combined insult of TAC and K ATP suppression in the SUR1-tg and Kir6.2 KO mice led to a decrease in total FOXO1, suggesting a synergistic effect of metabolic stress and K ATP channel activity on FOXO1 protein level.
We used rat neonatal cardiomyocytes to further characterize the effect of K ATP channels on PGC-1␣. Because the aim was to determine whether inhibition of K ATP channel activity would depress PGC-1␣ expression, we exposed the cells with H/R to activate the K ATP channels. Suppression of K ATP channel activity either with glibenclamide or by selective gene silencing of SUR2 significantly repressed expression of PGC-1␣ and its downstream target gene CPT-1b at mRNA level. Furthermore, both glibenclamide and knocking down SUR2 expression significantly reduced reporter activity driven by PGC-1␣ promoter, indicating that K ATP channels are able to influence PGC-1␣ expression at the transcriptional level. The studies in isolated cardiomyocytes were designed to examine whether the regulation of PGC-1␣ expression by K ATP channels might be a general response of heart under stress conditions. Although challenging cultured cells with H/R can effectively manipulate cardiomyocyte K ATP activity in the absence of changes in neurohormonal agents that occur in vivo, it does not cause myocyte hypertrophy. Therefore, the H/R study is not a specific or ideal model to mimic the in vivo pressure overload induced ventricular hypertrophy, which is a limitation of this study. However, it should be noted that Sano et al demonstrated that TAC does cause myocardial hypoxia in vivo, likely attributable to decreased vascular density in conjunction with increased metabolic demands secondary to increased cardiac work. 40 Taken together, using 2 mouse strains in which ventricular K ATP channel activity was disrupted, we demonstrate that loss of K ATP channel activity attenuated the expression of PGC-1␣ and mitochondrial energy metabolism-related enzymes in the heart and exacerbated TAC-induced ventricular hypertrophy and dysfunction, indicating a role for K ATP channels in the chronic response to increased cardiac work. We provide further evidence that the protective effect of K ATP occurs at least partially by regulating the activity of FOXO1, which, in turn, influences the expression of PGC-1␣ and its downstream target genes. Our findings support an important role for K ATP channels in regulating the myocardial expression of metabolism-related genes in the cardiac response to hemodynamic overload ( Figure 8D ).
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Material and Methods
Animals and Transverse Aortic Constriction (TAC)
Adult (12-15 weeks) high-expressing Line 720 SUR1-tg mice 1 and their WT littermates were used in this study. Kir6.2 KO mice 2 backcrossed for five generations into a C57BL/6 background were further crossed into a C57BL/6 background 2 additional times to generate heterozygous Kir6.2 mice as breeders. The homozygous Kir6.2 KO and wild type littermates produced were used for the study. PGC1α KO mice were generated as previously described 3 . All animal studies were performed according to a protocol approved by the University of Minnesota Institutional Animal
Care and Use Committee. Severe TAC (using a 27G needle to calibrate the degree of aortic constriction) was performed in SUR1-tg mice as described 4, 5 . Previous studies demonstrated that severe TAC caused a high mortality rate in both Kir6.2 KO 6 and PGC1α KO mice; consequently, to allow a 6 week observation period in these strains, moderate TAC (using a 26G needle to calibrate the degree of aortic constriction) was performed. Echocardiography was performed while the mice were anesthetized with 1.5% isoflurane by inhalation.
Western Blots and Quantitative Real-time PCR
Primary antibody against ANP was from Peninsula Lab., Bachem AG;
antibodies against PGC-1α, COXI, COXIII, UCP3, and SUR2A were from Santa Cruz Biotech; antibodies against cytochrome C, phos-Akt Ser472 , total-Akt, phos-FOXO1 Thr24 , total-FOXO1 were from Cell Signaling, and antibody against CPT-1b was from Alpha Diagnostics. HRP conjugated secondary antibodies were from BioRad Laboratories and Sigma.
Total RNA was reverse-transcribed using random hexamers and Moloney murine leukemia virus (MMLV) reverse transcriptase (Clontech). The real-time PCR reaction was carried out using the Light Cycler Thermocycler (Roche Diagnostics Corp). Primers are listed in Online Table II . Results were normalized to α-sarcomeric actin.
Cell Culture, Transfection, Reporter Gene Assay
Rat neonatal cardiomyocytes were isolated and cultured as described Reporter constructs were generated by inserting 3.1Kb PGC-1α promoter 8 into pGL3B vector (Promega). The mutations were introduced into the wild type reporter using QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene). LacZ reporter driven by CMV promoter was used as an internal control for transfection, and relative luciferase activity was determined by normalizing luciferase activity to the corresponding LacZ activity.
Preparation of Nuclear Extract
Frozen heart tissue was ground in liquid nitrogen into fine power and homogenized in hypotonic buffer. Rat neonatal cardiomyocytes were washed in DPBS (Invitrogen) and resuspended in hypotonic buffer. Then nuclear extract was prepared as described 9 .
ChIP Assay
ChIP assay was performed as described 10 . DNA was purified from the immunocomplex precipitated with anti-FOXO1 antibody and subjected to real-time PCR. Chromatin solutions with non-specfic IgG were used as control for total input.
Statistical Analysis
Results are expressed as mean ± standard error of the mean (SEM). The number of samples in each group for each experiment was at least six or as indicated in the legends. An unpaired two-tailed Student's t-test was used to determine p values. A p value of ≤ 0.05 was considered significant.
Online Table II Online Figure II . Ponseau S staining of the blots on PVDF membrane before Western blot for sample loading control of Figure 3A and Figure 3B . A, 25μg of total lysate resolved on 15% SDS-PAGE (gel used for Figure 3A) ; B, 75μg of total lysate resolved on 10% SDS-PAGE (gel used for Figure 3B ). Online Figure III . The mRNA levels of GAPDH in the SUR1-tg and WT mice after normalized to α-actin and 18SrRNA. The RT and realtime PCR results in this study were normalized to α-actin.
WT sham WT TAC WT TAC
SUR1-tg TAC SUR1-tg sham
Online Figure IV 
SUR1-tg TAC
Online Figure IV . Following TAC the mitochondria volume density is not significantly different between the SUR1-tg and WT mice.
